---
title: "Johnson & Johnson acquires Laminar"
date: "2023-11-30T14:09:25.000Z"
publishedDate: "30 novembre 2023"
summary: "Johnson &#38; Johnson MedTech has announced the completion of the acquisition of Laminar, a medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AF). Johnson &#38; Johnson MedTech acquired Laminar for an upfront payment of US$400 million, subject to customary adjustments, with additional potential clinical and regulatory [&#8230;] The post Johnson &#038; Johnson acquires Laminar appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/johnson-johnson-acquires-laminar/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-11-30-johnson-and-johnson-acquires-laminar"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/06/finance-business-funding.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/johnson-johnson-acquires-laminar/"
---

![Johnson & Johnson acquires Laminar](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/06/finance-business-funding.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/johnson-johnson-acquires-laminar/*

## L’essentiel

Johnson &#38; Johnson MedTech has announced the completion of the acquisition of Laminar, a medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AF). Johnson &#38; Johnson MedTech acquired Laminar for an upfront payment of US$400 million, subject to customary adjustments, with additional potential clinical and regulatory [&#8230;] The post Johnson &#038; Johnson acquires Laminar appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/johnson-johnson-acquires-laminar/
